Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	**comment**- imp inhalation solution identical to ventavis inhalation solution, but imp is in a different volume presentation. please see covering letter.	-	-	-	-	[1] 86 💬
2	0.5 mg budesonide effervescent tablet for orodispersible use	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
3	1 mg budesonide effervescent tablet for orodispersible use	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
4	120 mg sodium nitrite inhalation solution	Nitrite	-	-	-	[1] 86 💬
5	15 mg sodium nitrite inhalation solution	Nitrite	-	-	-	[1] 86 💬
6	1mg budesonide effervescent tablet for orodispersible use	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
7	25% mtd sodium nitrite inhalation solution	Nitrite	-	-	-	[1] 86 💬
8	2mg budesonide effervescent tablet for orodispersible use	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
9	4.2% nacl/inhalation solution	-	-	-	-	[1] 299 💬
10	45 mg sodium nitrite inhalation solution	Nitrite	-	-	-	[1] 86 💬
11	90 mg sodium nitrite inhalation solution	Nitrite	-	-	-	[1] 86 💬
12	Air001 (sodium nitrite inhalation solution)	Nitrite	-	-	-	[1] 86 💬
13	Air001 inhalation solution	-	-	-	-	[1] 86 💬
14	Air001 inhalation solution (expansion arm)	-	-	-	-	[1] 86 💬
15	Amiloride solution for inhalation	Amiloride	[2] D00649, D07447 💬	[3] SCNN1A, SCNN1B, SCNN1G 💬	[2] Aldosterone-regulated sodium reabsorption, Taste transduction	[1] 299 💬
16	Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed	Apomorphine	[2] D02004, D07460 💬	[2] DRD1, DRD2 💬	[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
17	Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed	Apomorphine	[2] D02004, D07460 💬	[2] DRD1, DRD2 💬	[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
18	Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed	Apomorphine	[2] D02004, D07460 💬	[2] DRD1, DRD2 💬	[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
19	Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed	Apomorphine	[2] D02004, D07460 💬	[2] DRD1, DRD2 💬	[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
20	Azd5634 for inhalation	-	-	-	-	[1] 299 💬
21	Aztreonam for inhalation (ai)	Aztreonam	[2] D00240, D06558 💬	-	-	[1] 299 💬
22	Aztreonam for inhalation solution	Aztreonam	[2] D00240, D06558 💬	-	-	[1] 299 💬
23	Aztreonam for inhalation solution (azli)	Aztreonam	[2] D00240, D06558 💬	-	-	[1] 299 💬
24	Aztreonam lysine for inhalation	Aztreonam	[3] D00240, D02304, D06558 💬	-	-	[1] 299 💬
25	Aztreonam lysine for inhalation (azli)	Aztreonam	[3] D00240, D02304, D06558 💬	-	-	[1] 228 💬
26	Budesonide	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[9] 66, 93, 94, 95, 96, 97, 98, 228, 299 💬
27	Budesonide ( zentacort capsules 3mg )	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 96 💬
28	Budesonide (6 mg)	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
29	Budesonide (9 mg)	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
30	Budesonide 0.5mg orodispersible tablet twice daily	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
31	Budesonide 1mg orodispersible tablet twice daily	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
32	Budesonide 6 mg capsules, hard (bux-pvii prototype)	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
33	Budesonide 6 mg prolonged-release capsule, hard (bux-pvii prototype)	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
34	Budesonide 6 mg prolonged-release capsules, hard (bux-pvii prototype)	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
35	Budesonide 9 mg capsules, hard (bux-pv)	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
36	Budesonide 9 mg capsules, hard (bux-pvii prototype)	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
37	Budesonide 9 mg prolonged-release capsule, hard (bux-pvii prototype)	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
38	Budesonide 9 mg prolonged-release capsules, hard (bux-pvii prototype)	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
39	Budesonide [0.4mg/ml] viscous suspension	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
40	Budesonide mmx	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
41	Budesonide mmx 6 mg tablet	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
42	Budesonide mmx®	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
43	Budesonide mmx® 6 mg	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
44	Budesonide mmx® 9 mg	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
45	Budesonide oral suspension	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
46	Budesonide oral suspension [0.2 mg/ml]	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
47	Budesonide plus prevacid	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
48	Budesonide-formoterol single inhaler	Budesonide	[4] D00246, D01373, D05277, D07990 💬	[2] ADRB2, NR3C1 💬	[8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 299 💬
49	Budesonide-mmx	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
50	Budesonide-mmx®	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
51	Budesonide-mmx® 6 mg	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
52	Budesonide-mmx® 9 mg	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
53	Budesonide-mmx™	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
54	Budesonide/formoterol	Budesonide	[4] D00246, D01373, D05277, D07990 💬	[2] ADRB2, NR3C1 💬	[8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 228 💬
55	Ceftazidime and tobramycin	Ceftazidime	[4] D00063, D00921, D02542, D07654 💬	-	-	[1] 299 💬
56	Ciprofloxacin (bayq3939) dry powder for inhalation	Ciprofloxacin	[2] D00186, D02216 💬	-	-	[1] 299 💬
57	Ciprofloxacin dispersion for inhalation	Ciprofloxacin	[2] D00186, D02216 💬	-	-	[1] 299 💬
58	Ciprofloxacin for inhalation	Ciprofloxacin	[2] D00186, D02216 💬	-	-	[1] 299 💬
59	Colimycine inhalation	-	-	-	-	[1] 299 💬
60	Combination oral budesonide and rectal hydrocortisone	Budesonide	[2] D00088, D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
61	Cyclosporine a dry powder inhalation (drug)	Cyclosporine	[1] D00184 💬	[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	[32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	[1] 228 💬
62	Cyclosporine inhalation solution	Cyclosporine	[1] D00184 💬	[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	[32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	[1] 228 💬
63	Cyclosporine inhalation solution (cis)	Cyclosporine	[1] D00184 💬	[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	[32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway	[1] 228 💬
64	Denufosol tetrasodium (ins37217) inhalation solution	Denufosol	[1] D03685 💬	-	-	[1] 299 💬
65	Denufosol tetrasodium inhalation solution	Denufosol	[1] D03685 💬	-	-	[1] 299 💬
66	Device: l606 inhalation system	-	-	-	-	[1] 86 💬
67	Dry powder tobramycin	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
68	Formoterol/budesonide	Budesonide	[4] D00246, D01373, D05277, D07990 💬	[2] ADRB2, NR3C1 💬	[8] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway	[1] 228 💬
69	Gm-csf inhalation therapy	-	-	-	-	[1] 229 💬
70	Helium / oxygen mixed gas inhalation therapy	Helium	[2] D00003, D04420 💬	-	-	[1] 330 💬
71	Heparin 25mg inhalation powder, hard capsule	Heparin	[1] D07510 💬	[1] SERPINC1 💬	[1] Complement and coagulation cascades	[1] 299 💬
72	High dose budesonide	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
73	High dose budesonide suspension	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
74	High dose budesonide tablet	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
75	High dose of budesonide	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 299 💬
76	Hyaluronic acid inhalation solution	Hyaluronic acid	[1] D08043 💬	-	-	[1] 231 💬
77	Iloprost inhalation solution (ventavis)	Iloprost	[1] D02721 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[2] 85, 86 💬
78	Inhalation	-	-	-	-	[1] 228 💬
79	Inhaled tobramycin	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
80	Inhaled/swallowed budesonide	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
81	Inomax 400ppm mol/mol inhalation gas	-	-	-	-	[2] 85, 299 💬
82	Iv tobramycin	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
83	Kamada -aat for inhalation or inhaled aat (aat)	-	-	-	-	[1] 231 💬
84	Kamada-aat for inhalation	-	-	-	-	[1] 231 💬
85	Kamada-aat for inhalation, 160mg	-	-	-	-	[1] 231 💬
86	Kamada-aat for inhalation, 80mg	-	-	-	-	[1] 231 💬
87	L606 (liposomal treprostinil) inhalation solution 51ug	Treprostinil	[1] D06213 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
88	Levodopa powder for inhalation	Levodopa	[1] D00059 💬	[5] DRD1, DRD2, DRD3, DRD4, DRD5 💬	[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway	[1]  6  💬
89	Liposomal amikacin for inhalation	Amikacin	[2] D00865, D02543 💬	-	-	[1] 299 💬
90	Liposomal amikacin for inhalation (arikayce™) using the pari investigational eflow® nebulizer.	Amikacin	[2] D00865, D02543 💬	-	-	[1] 299 💬
91	Low dose budesonide	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 97 💬
92	Low dose budesonide tablet	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
93	Mannitol inhalation powder	Mannitol	[1] D00062 💬	-	-	[1] 299 💬
94	Methylprednisolone or budesonide	Budesonide	[7] D00246, D00407, D00751, D00979, D05000, D05001, D05002 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 96 💬
95	Mp-376 (levofloxacin solution for inhalation)	Levofloxacin	[2] D00588, D08120 💬	-	-	[1] 299 💬
96	Nebcin (tobramycin)	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
97	Nebulization tobramycin	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
98	Nitric oxide for inhalation	Nitric Oxide	[1] D00074 💬	-	-	[2] 86, 299 💬
99	Oligog cf-5/20, 17,5 mg, hartkapsel mit pulver zur inhalation	-	-	-	-	[1] 299 💬
100	Oligog cf/20, 27,5 mg, hartkapsel mit pulver zur inhalation	-	-	-	-	[1] 299 💬
101	Oligog cf/20, 37,5 mg, hartkapsel mit pulver zur inhalation	-	-	-	-	[1] 299 💬
102	Oligog dry powder for inhalation	-	-	-	-	[1] 299 💬
103	Oral budesonide	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
104	Oral budesonide suspension (mb-9)	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
105	Oral budesonide suspension (obs)	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
106	Oral viscous budesonide	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
107	Oral viscous budesonide (ovb)	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬
108	Other: tobramycin time of administration	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
109	Radiolabelled oligog cf-5/20 dry powder for inhalation (dpi)	-	-	-	-	[1] 299 💬
110	Rt234 - vardenafil inhalation powder	Vardenafil	[3] D02731, D03260, D08668 💬	[1] PDE5A 💬	[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway	[1] 86 💬
111	Saline 0.9% inhalation solution	-	-	-	-	[1] 299 💬
112	Sodium nitrite inhalation solution	Nitrite	-	-	-	[1] 86 💬
113	Spiriva respimat 2.5 microgram, solution for inhalation	-	-	-	-	[1] 299 💬
114	Tiotropium respimat 1.25 microgram solution for inhalation	Tiotropium	-	-	-	[1] 299 💬
115	Tiotropium respimat 1.25 microgram, solution for inhalation	Tiotropium	-	-	-	[1] 299 💬
116	Tiotropium respimat 1.25 micrograms solution for inhalation	Tiotropium	-	-	-	[1] 299 💬
117	Tip (tobramycin inhalation powder)	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
118	Tis (tobramycin inhalation solution)	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
119	Tobi (tobramycin)	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
120	Tobi 300 mg/5 ml, solution pour inhalation par nébuliseur	-	-	-	-	[1] 299 💬
121	Tobi podhaler 28 mg hartkapseln mit pulver zur inhalation	-	-	-	-	[1] 299 💬
122	Tobramycin	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
123	Tobramycin (gernebcin®)	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
124	Tobramycin / bramitob	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
125	Tobramycin / tobi	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
126	Tobramycin 100 pari	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
127	Tobramycin dry powder	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
128	Tobramycin for inhalation	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
129	Tobramycin inhalation powder	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
130	Tobramycin inhalation powder (tip)	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
131	Tobramycin inhalation powder tip delivered by the t-326 inhaler	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
132	Tobramycin inhalation solution	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
133	Tobramycin inhalation solution (tis)	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
134	Tobramycin inhalation solution using a pari lc® plus nebulizer.	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
135	Tobramycin injection 40mg/1ml	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
136	Tobramycin nebulized nasally	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
137	Tobramycin powder	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
138	Tobramycin solution for inhalation	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
139	Tobramycin solution for inhalation (tobi)	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
140	Tobramycin solution for inhalation 300 mg	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
141	Tobramycin steri-neb 300 mg/5 ml, inhalation solution	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
142	Tobramycin sulfate	Sulfate ion	[2] D00063, D02542 💬	-	-	[1] 299 💬
143	Treprostinil inhalation powder	Treprostinil	[1] D06213 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
144	Treprostinil inhalations	Treprostinil	[1] D06213 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
145	Treprostinil sodium for inhalation	Treprostinil	[1] D06213 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 85 💬
146	Treprostinil sodium solution for inhalation	Treprostinil	[1] D06213 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
147	Tyvaso inhalation solution	-	-	-	-	[1] 86 💬
148	Vancomycin hydrochloride inhalation powder	Vancomycin	[2] D00212, D00926 💬	-	-	[1] 299 💬
149	Vancomycin inhalation powder	Vancomycin	[2] D00212, D00926 💬	-	-	[1] 299 💬
150	Vantobra (tobramycin)	Tobramycin	[2] D00063, D02542 💬	-	-	[1] 299 💬
151	Viscous/swallowed budesonide	Budesonide	[1] D00246 💬	[1] NR3C1 💬	[1] Neuroactive ligand-receptor interaction	[1] 98 💬

Back to top